GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 116 filers reported holding GOSSAMER BIO INC in Q2 2021. The put-call ratio across all filers is 7.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $210,000 | +44.8% | 17,496 | +0.7% | 0.08% | +55.6% |
Q2 2022 | $145,000 | +10.7% | 17,370 | +15.5% | 0.05% | -8.5% |
Q1 2022 | $131,000 | -27.2% | 15,039 | -5.6% | 0.06% | -13.2% |
Q4 2021 | $180,000 | -40.6% | 15,932 | -33.9% | 0.07% | -48.9% |
Q3 2021 | $303,000 | +47.1% | 24,110 | -4.9% | 0.13% | +56.5% |
Q2 2021 | $206,000 | -21.7% | 25,361 | -10.9% | 0.08% | -23.4% |
Q1 2021 | $263,000 | -2.6% | 28,463 | +1.8% | 0.11% | -0.9% |
Q4 2020 | $270,000 | -13.5% | 27,963 | +11.3% | 0.11% | -31.7% |
Q3 2020 | $312,000 | -15.9% | 25,129 | -12.0% | 0.16% | -6.8% |
Q2 2020 | $371,000 | +157.6% | 28,554 | +101.6% | 0.18% | +198.3% |
Q1 2020 | $144,000 | -43.3% | 14,166 | -12.8% | 0.06% | +40.5% |
Q4 2019 | $254,000 | +21.5% | 16,245 | +30.2% | 0.04% | 0.0% |
Q3 2019 | $209,000 | -28.4% | 12,473 | -5.3% | 0.04% | -32.3% |
Q2 2019 | $292,000 | – | 13,168 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |